Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 2
1913 1
1917 1
1919 1
1921 3
1922 1
1923 2
1934 1
1936 1
1940 1
1942 2
1945 2
1946 3
1947 1
1948 1
1949 1
1950 1
1951 1
1955 2
1956 2
1963 1
1966 1
1967 1
1968 1
1970 2
1971 4
1972 1
1973 2
1974 5
1975 7
1976 4
1977 2
1978 4
1979 3
1980 8
1981 3
1982 3
1983 3
1984 1
1985 5
1986 8
1987 8
1988 9
1989 6
1990 5
1991 6
1992 11
1993 2
1994 4
1995 13
1996 7
1997 7
1998 6
1999 9
2000 6
2001 5
2002 6
2003 19
2004 10
2005 16
2006 28
2007 20
2008 35
2009 34
2010 44
2011 51
2012 87
2013 82
2014 81
2015 83
2016 89
2017 107
2018 115
2019 78
2020 106
2021 120
2022 109
2023 121
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,518 results

Results by year

Filters applied: . Clear all
Page 1
Leptin and obesity.
Seth M, Biswas R, Ganguly S, Chakrabarti N, Chaudhuri AG. Seth M, et al. Among authors: ganguly s. Physiol Int. 2020 Dec 22;107(4):455-468. doi: 10.1556/2060.2020.00038. Physiol Int. 2020. PMID: 33355539 Review.
From bench to bedside: the history and progress of CAR T cell therapy.
Mitra A, Barua A, Huang L, Ganguly S, Feng Q, He B. Mitra A, et al. Among authors: ganguly s. Front Immunol. 2023 May 15;14:1188049. doi: 10.3389/fimmu.2023.1188049. eCollection 2023. Front Immunol. 2023. PMID: 37256141 Free PMC article. Review.
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Passaro A, et al. Among authors: ganguly s. Ann Oncol. 2024 Jan;35(1):77-90. doi: 10.1016/j.annonc.2023.10.117. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879444 Free article. Clinical Trial.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Shadman M, Pasquini M, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi PN, Beitinjaneh A, Reagan PM, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M. Shadman M, et al. Among authors: ganguly s. Blood. 2022 Mar 3;139(9):1330-1339. doi: 10.1182/blood.2021013289. Blood. 2022. PMID: 34570879 Free PMC article.
Heterogeneity of HSCs in a Mouse Model of NASH.
Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, Li RZ, Troutman TD, Kisseleva T, Glass CK, Brenner DA. Rosenthal SB, et al. Among authors: ganguly s. Hepatology. 2021 Aug;74(2):667-685. doi: 10.1002/hep.31743. Epub 2021 Aug 10. Hepatology. 2021. PMID: 33550587 Free PMC article.
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States.
Jacobson CA, Locke FL, Ma L, Asubonteng J, Hu ZH, Siddiqi T, Ahmed S, Ghobadi A, Miklos DB, Lin Y, Perales MA, Lunning MA, Herr MM, Hill BT, Ganguly S, Dong H, Nikiforow S, Hooper M, Kawashima J, Xu H, Pasquini MC. Jacobson CA, et al. Among authors: ganguly s. Transplant Cell Ther. 2022 Sep;28(9):581.e1-581.e8. doi: 10.1016/j.jtct.2022.05.026. Epub 2022 May 21. Transplant Cell Ther. 2022. PMID: 35609867 Free PMC article.
Gentian violet: Revisited.
Prabha N, Arora RD, Ganguly S, Chhabra N. Prabha N, et al. Among authors: ganguly s. Indian J Dermatol Venereol Leprol. 2020 Sep-Oct;86(5):600-603. doi: 10.4103/ijdvl.IJDVL_579_19. Indian J Dermatol Venereol Leprol. 2020. PMID: 32769306 Free article. Review. No abstract available.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Masiarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz R, Romee R, Riches M. Goldsmith SR, et al. Among authors: ganguly s. Blood. 2021 Jun 10;137(23):3291-3305. doi: 10.1182/blood.2020009362. Blood. 2021. PMID: 33657221 Free PMC article. Clinical Trial.
Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial.
Bahlis NJ, Siegel DS, Schiller GJ, Samaras C, Sebag M, Berdeja J, Ganguly S, Matous J, Song K, Seet CS, Acosta-Rivera M, Bar M, Quick D, Anz B, Fonseca G, Chung W, Lee K, Mouro J, Agarwal A, Reece D. Bahlis NJ, et al. Among authors: ganguly s. Leuk Lymphoma. 2022 Jun;63(6):1407-1417. doi: 10.1080/10428194.2022.2030477. Epub 2022 Feb 8. Leuk Lymphoma. 2022. PMID: 35133221 Clinical Trial.
1,518 results